CGI
LLY icon

Comgest Global Investors’s Eli Lilly LLY Stock Holding History

Comgest Global Investors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132M Sell
110,028
-20,758
-16% -$21.2M 2.9% 13
2026
Q1 		$120M Sell
130,786
-78,469
-37% -$79.6M 2.62% 15
2025
Q4 		$225M Sell
209,255
-63,151
-23% -$60.4M 4.01% 10
2025
Q3 		$208M Sell
272,406
-89,083
-25% -$66.3M 3.68% 11
2025
Q2 		$282M Sell
361,489
-87,467
-19% -$68M 4.81% 9
2025
Q1 		$371M Sell
448,956
-147,173
-25% -$122M 6.62% 5
2024
Q4 		$460M Buy
596,129
+21,887
+4% +$18.1M 7.54% 2
2024
Q3 		$509M Sell
574,242
-138,561
-19% -$125M 7.28% 4
2024
Q2 		$645M Sell
712,803
-31,172
-4% -$24.9M 8.86% 4
2024
Q1 		$579M Sell
743,975
-82,463
-10% -$58.7M 8.06% 4
2023
Q4 		$482M Sell
826,438
-46,650
-5% -$27.2M 7.23% 4
2023
Q3 		$469M Sell
873,088
-117,020
-12% -$60.3M 8.03% 4
2023
Q2 		$464M Sell
990,108
-14,711
-1% -$6.17M 7.76% 4
2023
Q1 		$345M Sell
1,004,819
-70,206
-7% -$23.7M 6.47% 4
2022
Q4 		$393M Sell
1,075,025
-185,874
-15% -$65.9M 8.68% 2
2022
Q3 		$408M Sell
1,260,899
-18,691
-1% -$5.92M 8.97% 1
2022
Q2 		$415M Sell
1,279,590
-198,842
-13% -$59.7M 8.15% 2
2022
Q1 		$423M Sell
1,478,432
-55,397
-4% -$14.3M 6.62% 5
2021
Q4 		$424M Buy
1,533,829
+3,758
+0.2% +$953K 5.63% 6
2021
Q3 		$354M Sell
1,530,071
-105,809
-6% -$26.1M 4.63% 8
2021
Q2 		$375M Sell
1,635,880
-112,327
-6% -$22.6M 5.1% 7
2021
Q1 		$327M Buy
1,748,207
+84,482
+5% +$16.5M 5% 9
2020
Q4 		$281M Buy
1,663,725
+84,778
+5% +$12.7M 4.93% 8
2020
Q3 		$234M Buy
1,578,947
+304,686
+24% +$47.2M 3.5% 10
2020
Q2 		$209M Sell
1,274,261
-98,095
-7% -$15.1M 3.51% 11
2020
Q1 		$190M Sell
1,372,356
-150,398
-10% -$20.7M 3.88% 11
2019
Q4 		$200M Sell
1,522,754
-52,946
-3% -$6.14M 3.61% 13
2019
Q3 		$176M Buy
1,575,700
+113,400
+8% +$12.6M 3.59% 13
2019
Q2 		$162M Buy
1,462,300
+182,100
+14% +$21.4M 3.52% 13
2019
Q1 		$166M Sell
1,280,200
-341,900
-21% -$41.6M 3.64% 11
2018
Q4 		$188M Buy
1,622,100
+74,200
+5% +$8.29M 4.64% 9
2018
Q3 		$166M Buy
1,547,900
+227,200
+17% +$22.7M 3.73% 10
2018
Q2 		$113M Buy
1,320,700
+364,200
+38% +$29.9M 2.5% 11
2018
Q1 		$74M Buy
956,500
+38,700
+4% +$3.12M 1.62% 15
2017
Q4 		$77.5M Sell
917,800
-45,700
-5% -$3.89M 1.68% 14
2017
Q3 		$82.4M Buy
963,500
+12,400
+1% +$1.02M 1.92% 13
2017
Q2 		$78.3M Buy
951,100
+208,200
+28% +$17M 1.94% 13
2017
Q1 		$62.5M Buy
742,900
+633,900
+582% +$50.8M 1.68% 14
2016
Q4 		$8.02M Buy
109,000
+22,500
+26% +$1.68M 0.26% 23
2016
Q3 		$6.94M Buy
86,500
+20,500
+31% +$1.64M 0.21% 26
2016
Q2 		$5.2M Buy
66,000
+23,000
+53% +$1.73M 0.16% 28
2016
Q1 		$3.1M Buy
43,000
+13,000
+43% +$984K 0.11% 32
2015
Q4 		$2.53M Buy
30,000
+17,000
+131% +$1.41M 0.08% 35
2015
Q3 		$1.09M Buy
+13,000
New +$1.1M 0.04% 43

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Comgest Global Investors's LLY Position: Q2 2026 in Review

Comgest Global Investors reduced its Eli Lilly (LLY) stake by 16% in Q2 2026, selling an estimated $21.2M and leaving 110,028 shares worth $132M. The position accounts for 2.9% of the portfolio, ranked #13.

Comgest Global Investors first reported a position in LLY in Q3 2015 and has held it in 44 quarters since. The position peaked at $645M in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Comgest Global Investors held 110,028 shares of Eli Lilly worth $132M as of Q2 2026.
  • Comgest Global Investors sold 20,758 Eli Lilly shares in Q2 2026, an estimated $21.2M.
  • Eli Lilly made up 2.9% of Comgest Global Investors's portfolio in Q2 2026, its #13 holding.
  • Comgest Global Investors first reported a position in Eli Lilly in Q3 2015 and has held it in 44 quarters since.
  • Comgest Global Investors's Eli Lilly position peaked at $645M in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Comgest Global Investors's 13F filing for Q2 2026, filed 24 Jul 2026.